DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20184226

Tuberculosis: an experience at government chest disease hospital

Syed S. A. Farooq, Nazia Mehfooz, Khurshid A. Dar, Naveed N. Shah, Faheem Gul, Tariq Sultan

Abstract


Background: This retrospective study was carried out to find the incidence, clinical profiles and treatment outcome of pulmonary and extrapulmonary tuberculosis patients attending the only Chest Disease Hospital in Srinagar.

Methods: A retrospective analysis of 613 patients having EPTB and PTB was undertaken from the chest disease hospital of Government Medical College Srinagar. Demographic characteristics, clinical features and treatment outcome were obtained from medical case records of all patients visiting the hospital for a period of two years from May 2016-May 2018.

Results: The study comprised of 613 patients, out of which 365% were having pulmonary TB while 35% were having extrapulmonary TB. Majority of patients (44.5%) in TB group were in age group 10-30 while majority of patients (42%) in EPTB group were in age group 51-70. Males were seen more commonly affected. Majority (90%) of patients in EPTB group had pleural effusion. Majority of patients (71%) were smear positive by ZN staining in PTB group. Majority (90%) of PTB patients in smear negative group were BAL negative. In PTB group 8% were treatment failure while in EPTB group 2% were treatment failure. MDR was seen in 4.2% of total tuberculosis patient while XDR was seen in 0.32% of total patients. Out of treatment failure in PTB group MDR was seen in 64% followed by monoresistance to INH in 30% and XDR in 6%. In EPTB group MDR was seen in 100% of treatment failure. All patients with XDR died. Among the MDR patients majority are on treatment while 12% died, another 12% defaulter while 12% completed treatment.

Conclusions: Among evaluated tuberculosis patients, maximum had PTB. Pleural tuberculosis was the most common presentation of EPTB. The study shows male preponderance in both groups. Treatment response was excellent with failure rate of 8% in PTB and 2% in EPTB. Most common cause of failure was MDR. XDR was seen in two patients and both of them died.


Keywords


BAL, Extra pulmonary TB (EPTB), Failure, MDR, Pulmonary TB (PTB), XDR, ZN staining

Full Text:

PDF

References


Revised national TB control Programme. Technical and operational guidelines for TB control in India. 2016:17-18.

Carrol ED, Clark JE, Cant AJ. Non-pulmonary tuberculosis. Paediatric Respiratory Reviews. 2001;2(2):113-9.

Golden MP, Vikram HR. Extrapulmonary tuberculosis: an overview. Am Fam Physician. 2005;72:1761-8.

Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38:199-205.

Arora VK, Chopra KK. Extrapulmonary Tuberculosis. Indian J Tuber. 2007;54(4):165-7.

Mohan A, Sharma SK. Epidemiology in Tuberculosis. New Delhi: Jaypee Brothers Medical Publishers. 2001;14-29.

Mohammed T, Daniel K, Helamo D, Leta T. Treatment outcomes of tuberculosis patients in nigist Eleni Mohammed general hospital, hosanna, southern nations, nationalities and peoples region, Ethiopia: a five year (June 2009 to August 2014) retrospective study. Archives of Public Health. 2017 Dec;75(1):16.

Gaur PS, Bhaskar R, Singh S, Saxena P, Agnihotri S. Incidence and clinical profiles of pulmonary and extra-pulmonary tuberculosis patients in North Indian population: a hospital based retrospective study. IJRDPL. 2017;6(5):2773-8.

Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120:316-53.

Lawrence MD, Baveja CP, Kumar S, Khanna A, Sapriina J. Comparative Evaluation of Flourescent Staining with Ziehl-Neelsen and Kinyoun Staining in the Diagnosis of Clinically Suspected Cases of Pulmonary Tuberculosis. Int J Contem Med Res. 2016;3(7):1970-4.

Arora VK, Singla N, Sarin R. Profile of geriatric patients under DOTS in Revised National Tuberculosis Control Programme. Indian J Chest Dis Allied Sci. 2003;45:231-5.

Rock RB, Sutherland WM, Baker C, Williams DN. Extrapulmonary tuberculosis among Somalis in Minnesota. Emerging infectious diseases. 2006 Sep;12(9):1434-6.

Yassin MA, Datiko DG, Shargie EB. Ten-year experiences of the tuberculosis control programme in the southern region of Ethiopia. The International J Tuber Lung Dis. 2006 Oct 1;10(10):1166-71.

Arora VK, Gupta R. Trends of extra-pulmonary tuberculosis under revised national tuberculosis control programme: A study from South Delhi. Indian J Tuberculosis. 2006 Apr 1;53(2):77.

Desai K, Malek S, Mehtaliya C. Comparative study of ZN staining v/s fluorochrome stain from pulmonary & extra-pulmonary tuberculosis. Gujarat Medical Journal. 2009;64(2):32-4.

Banavalikar JN, Gupta R, Sharma DC, Goel MK, Kumari S. HIV seropositivity in hospitalised pulmonary tuberculosis patients in Delhi. Indian J Tuberculosis. 1997;44:17-20.

Prakasha SR, Suresh G, D’sa IP, Shetty SS, Kumar SG. Mapping the pattern and trends of extrapulmonary tuberculosis. J Global Infectious Dis. 2013 Apr;5(2):54-9.

Chander V, Raina SK, Bhardwaj AK, Kashyap S, Gupta AK, Sood A. Clinico-epidemiological profile of extra pulmonary tuberculosis: a report from a high prevalence state of Northern India. Public Health Res. 2012;2(6):185-9.

Cherian JJ, Lobo I, Sukhlecha A, Chawan U, Kshirsagar NA, Nair BL, et al. Treatment outcome of extrapulmonary tuberculosis under Revised National Tuberculosis Control Programme. Ind J Tuber. 2017 Apr 1;64(2):104-8.

Gadoev J, Asadov D, Tillashaykhov M, Tayler-Smith K, Isaakidis P, Dadu A, et al. Factors associated with unfavorable treatment outcomes in new and previously treated TB patients in Uzbekistan: a five year countrywide study. PloS one. 2015 Jun 15;10(6):e0128907.

Khan EA, Starke JR. Diagnosis of tuberculosis in children: increased need for better methods. Emerging infectious diseases. 1995 Oct;1(4):115.

Marais BJ, Brittle W, Painczyk K, Hesseling AC, Beyers N, Wasserman E, et al. Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clinical Infectious Diseases. 2008;47(2):203-7.

Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. The Lancet infectious diseases. 2003 May 1;3(5):288-96.

Ganoza CA, Ricaldi JN, Chauca J, Rojas G, Munayco C, Agapito J, et al. Novel hypertonic saline–sodium hydroxide (HS–SH) method for decontamination and concentration of sputum samples for Mycobacterium tuberculosis microscopy and culture. J Med Microbiol. 2008 Sep 1;57(9):1094-8.

Karstaedt AS, Jones N, Khoosal M, Crewe-Brown HH. The bacteriology of pulmonary tuberculosis in a population with high human immunodeficiency virus seroprevalence. Inter J Tuberculosis Lung Disease. 1998 Apr 1;2(4):312-6.

Pipatvech K, Kiatboonsri S, Boonsarngsuk V, Hongmanee P, Choothakan S. The Value of Post-bronchoscopic Sputum Examination in the Diagnosis of Smear-Negative Pulmonary Tuberculosis. Thai J Tuber Chest Dis Crit Care. 2007;29(1):45-50.

Kalawat U, Sharma KK, Reddy PN, Kumar AG. Study of bronchoalveolar lavage in clinically and radiologically suspected cases of pulmonary tuberculosis. Lung India: official organ of Indian Chest Society. 2010 Jul;27(3):122.

Yüksekol I, Bal S, Ozkan M, Balkan A, Bedirhan I, Tozkoparan E, Demirci N, et al. The value of fiberoptic bronchoscopy in diagnosis of smear negative pulmonary tuberculosis. Tuberkuloz ve toraks. 2003;51(4):405-9.

Nikbakhsh N, Bayani M, Siadati S. The Value of Bronchoalveolar Lavage in the Diagnosis of Sputum Smear-Negative Pulmonary Tuberculosis. Iranian journal of pathology. 2015;10(1):35.

Shin JA, Chang YS, Kim TH, Kim HJ, Ahn CM, Byun MK. Fiberoptic bronchoscopy for the rapid diagnosis of smear-negative pulmonary tuberculosis. BMC infectious diseases. 2012;12(1):141.

Fatiregun AA, Ojo AS, Bamgboye AE. Treatment outcomes among pulmonary tuberculosis patients at treatment centers in Ibadan, Nigeria. Annals of African medicine. 2009;8(2).

Muttath R, Andrews M, Prabhu D. Treatment outcome in new smear positive pulmonary tuberculosis patients with and without immunosuppression on RNTCP regimen: a comparative observational study. Inter J Res Med Sci. 2017 Jan 23;5(2):384-7.

Liu CH, Li L, Chen Z, Wang Q, Hu YL, Zhu B, Woo PC. Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience. PloS one. 2011 Apr 29;6(4):e19399.

Alene KA, Yi H, Viney K, McBryde ES, Yang K, Bai L, et al. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China. BMC infectious diseases. 2017 Dec;17(1):573.

Waghmare MA, Utpat K, Joshi JM. Treatment outcomes of drug-resistant pulmonary tuberculosis under programmatic management of multidrug-resistant tuberculosis, at tertiary care center in Mumbai. Medical J Dr. DY Patil University. 2017 Jan 1;10(1):41.

Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, Thorpe LE, et al. Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. The Lancet. 2005 Jan 22;365(9456):318-26.

Prajapati K, Mishra V, Desai M, Solanki R, Naik P. Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India. International J Mycobacteriol. 2017 Jul 1;6(3):289.

Masjedi MR, Tabarsi P, Baghaei P, Jalali S, Farnia P, Chitsaz E, et al. Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients. Inter J Infectious Dis. 2010 May 1;14(5):e399-402.